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Abstract Mycobacterium massiliense (Mmass) is an emerg-
ing, rapidly growing mycobacterium (RGM) that belongs to
the M. abscessus (Mabc) group, albeit clearly differentiated
from Mabc. Compared with M. tuberculosis, a well-
characterized human pathogen, the host innate immune re-
sponse against Mmass infection is largely unknown. In this
study, we show that Mmass robustly activates mRNA and
protein expression of tumor necrosis factor (TNF)-α and
interleukin (IL)-6 in murine bone marrow-derived macro-
phages (BMDMs). Toll-like receptor (TLR)-2 and myeloid
differentiation primary response gene 88 (MyD88), but nei-
ther TLR4 nor Dectin-1, are involved in Mmass-induced
TNF-α or IL-6 production in BMDMs. Mmass infection also
activates the mitogen-activated protein kinase (MAPKs; c-Jun
N-terminal kinase (JNK), ERK1/2 and p38 MAPK) pathway.
Mmass-induced TNF-α and IL-6 production was dependent
on JNK activation, while they were unaffected by either the
ERK1/2 or p38 pathway in BMDMs. Additionally, intracel-
lular reactive oxygen species (ROS), NADPH oxidase-2, and
nuclear factor-κB are required for Mmass-induced proinflam-
matory cytokine generation in macrophages. Furthermore, the
S morphotype of Mmass showed lower overall induction of
pro-inflammatory (TNF-α, IL-6, and IL-1β) and anti-
inflammatory (IL-10) cytokines than the R morphotype,
suggesting fewer immunogenic characteristics for this
clinical strain. Together, these results suggest that
Mmass-induced activation of host proinflammatory cy-
tokines is mediated through TLR2-dependent JNK and
ROS signaling pathways.
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Introduction
Rapidly growing mycobacteria (RGM) are emerging human
pathogens causing diverse non-tuberculous mycobacterial
(NTM) diseases, especially opportunistic infections in immu-
nocompromised patients [1]. In recent years, the numbers of
RGM and newly identified NTMs have increased markedly in
the clinical field due to improved genetic identification
methods for mycobacterial species [2–4]. Mycobacterium
massiliense (Mmass) is a recently isolated RGM strain, which
belongs to theM. abscessus (Mabc) group, because it has high
similarity in genetic sequences with Mabc [5]. However, they
are clinically and genetically separate species. In clinical
aspects, treatment outcomes with clarithromycin therapy are
much better in patients infected with Mmass than in those
infected with Mabc [6].
A fine balance in inflammatory responses triggered by
mycobacterial infection is important in mounting host protec-
tive immune responses and the establishment of mature gran-
ulomas [7]. The proinflammatory cytokine tumor necrosis
factor (TNF)-α is known to play a central role in the formation
of granulomas, the sites of protection and pathology in tuber-
culosis [8–10]. Anti-TNF-α immunotherapy has been associ-
ated with increased risk of tuberculosis reactivation due in part
to a decrease in antimicrobial activity and CD8+ effector
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memory T cell activation [11, 12]. These results are consistent
with previous work showing that both TNF-α and interleukin
(IL)-6 play a role in controllingM. tuberculosis (Mtb) bacterial
infection, with significant impacts on survival in a mouse
model of Mtb infection [13, 14]. In vivo analyses of Mabc
infection further support a role for TNF-α as a critical medi-
ator of bacterial inhibition in liver and spleens, controlling
both hepatic inflammation and granuloma formation [15]; a
more detailed examination of the cytokine profiles elicited
during Mmass infection has not been performed.
Recent studies on Toll-like receptor (TLR) signaling during
mycobacterial infection have revealed the molecular mecha-
nisms by which mycobacteria and their ligands induce innate
defense and proinflammatory responses [16, 17]. TLR-
triggered innate immune responses are regulated by complex
intracellular signaling cascades involving nuclear factor
(NF)-κB and mitogen-activated protein kinase (MAPK) path-
ways [16, 18]. Both signaling pathways play key roles in the
activation of antimicrobial responses and in the generation of
effector molecules during mycobacterial infection [19]. More-
over, reactive oxygen species (ROS), derived primarily from
NADPH oxidases (NOX), are important in shaping and con-
trolling the key signaling network system redox-regulation-
during infectious and inflammatory responses [20, 21]. Previ-
ous studies have also shown that Mtb triggers ROS genera-
tion, and ROS play a role in proinflammatory responses in
macrophages [22]. However, the host innate immune re-
sponses against Mmass infection has remained largely un-
known, compared with what is known about Mtb or other
NTM infections, such as with Mabc.
In this study, we investigated the intracellular signaling
pathways activated by Mmass infection in murine bone
marrow-derived macrophages (BMDMs). First, we deter-
mined whether Mmass induced TNF-α and IL-6 production
in BMDMs. We then examined the roles of TLR2, TLR4,
MyD88, and Dectin-1 in Mmass-mediated TNF-α and IL-6
production in BMDMs. We further examined the activation of
the MAPK pathway (c-Jun N-terminal kinase (JNK), ERK1/2
and p38 MAPK), NF-κB, and ROS by Mmass infection and
the role by which MAPK and ROS regulate Mmass-induced
proinflammatory responses in BMDMs. Finally, we examined
the profiles of proinflammatory signaling activation in mac-
rophages in response to infection with Mmass clinical strains,
the R and S morphotypes.
Materials and Methods
Cultures of Mmass and Mabc
Mmass of type strain CIP 108297, two clinical smooth strains
(KMRC00136-13008 and KMRC00136-13011) and two clin-
ical rough strains (KMRC00136-13009 and KMRC00136-
13012) were obtained from The Korean Institute of Tubercu-
losis (Osong, Korea). The Mabc type strain ATCC 19977 and
all Mass strains were cultured as described previously [23].
All type-strain colonies exhibited smooth morphotypes. The
mycobacteria were grown in Middlebrook 7H9 medium
(Difco Laboratories, Detroit, MI, USA) with 10 % OADC
supplement (BD Pharmingen, San Diego, CA, USA), 0.5 %
glycerol, and 0.05 % Tween 80 (Sigma-Aldrich, St. Louis,
MO, USA) at 37 °C. Mmass and Mabc were collected by
centrifugation, homogenization, and filtration. Frozen bacteria
were stored at −70 °C. Representative Mmass and Mabc vials
were thawed and the numbers of colony forming units on
Middlebrook 7H10 agar plates were counted.
Mice and Ethics Statement
Mice with the C57BL/6 wild-type (WT) background were
purchased from SAMTAKO BIO KOREA (Gyeonggi-do,
Korea), C3H/HeN (TLR4 wild-type) and C3H/HeJ (TLR4-
deficient) mice were purchased from The Jackson Laboratory
(Bar Harbor, ME, USA). All mice were on the C57BL/6
background. TLR2, MyD88, and TRIF-knockout (KO) mice
were kindly provided by Dr. S. Akria (Osaka University,
Japan) and NOX2 KO mice were kindly provided by Dr.
Bae (Iwha University, Korea). This study was approved by
the Institutional Research and Ethics Committee at Chungnam
National University. All animal procedures were conducted in
accordance with the guidelines of the Korean Food and Drug
Administration (KFDA).
Culture of BMDMs and Cell Lines
BMDMs and Raw264.7 cell line were cultured as described
previously [24]. The BMDMs (Lonza; Walkersville, MD,
USA)were frommice sacrificed at 6-8 weeks of age. BMDMs
were isolated from femurs of mice killed by cervical disloca-
tion and cultured for 4 days in 20 μg/mL macrophage colony-
stimulating factor (R&D Systems, Minneapolis, MN, USA)
and supplement-containing culture medium (Dulbecco’s mod-
ified Eagle’s medium, 10 % heat-inactivated fetal bovine
serum, 1 mM sodium pyruvate, 50 U/mL penicillin, and
50 μg/mL streptomycin). Murine macrophage RAW264.7
cells (ATCC TIB-71; Manassas, VA, USA) were grown in
supplement-containing culture medium.
Reagents
Lipopolysaccharides (LPS; Escherichia coli 0111:B4) and
synthetic bacterial lipopeptide (Pam3Cys-Ser-Lys4-OH) were
from InvivoGen (San Diego, CA, USA). N-acetylcysteine
(NAC), diphenyleneiodonium (DPI), BAY11-7082 (BAY),
caffeic acid phenethyl ester (CAPE), U0126, SB203580, and
SP600125 were from Calbiochem (San Diego, CA, USA).
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4,5-dihydroxy-1,3-benzene disulfonic acid disodium salt
(Tiron) and dimethyl sulfoxide (DMSO; added to the cultures
at 0.05% (v/v) as a solvent control) were from Sigma-Aldrich.
Phospho-SAPK/JNK (Thr183/Tyr185), phospho-ERK1/2
(Thr202/Tyr204), and phospho-p38 (Thr180/Tyr182) were
from Cell Signaling Technology (Cell Signaling; Beverly,
MA, USA). β-actin (I-19) was obtained from Santa Cruz
Biotechnology (Santa Cruz, CA, USA).
Western Blot Analysis and Enzyme-Linked Immunosorbent
Assay (ELISA)
Western blot analysis and ELISA were conducted as
described previously [23]. For Western blotting, whole
protein extracts were denatured by boiling and resolved
in 12 % acrylamide SDS-PAGE gels. Then, proteins
were transferred to a polyvinyl difluoride membrane
(Millipore, Boston, MA, USA). For Western blotting,
primary antibodies were diluted at a ratio of 1:1000.
The membranes were developed with ECL solution
(Millipore) and were exposed to chemiluminescence
film (Fujifilm, Japan).
For ELISA (BD PharMingen), infected cell supernatants
were assessed for TNF-α, IL-6, IL-1β and IL-10 secretion using
Duoset antibody pairs, according to themanufacturer’s protocol.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
Analysis
For semi-quantitative RT-PCR analysis, total RNA was ex-
tracted from cells using TRIzol (Invitrogen, Carlsbad, CA,
USA), as described previously [23]. Primer sequences were as
follows: TNFα (forward: 5′-CGGACTCCGCAAAGTCTA
AG-3′, reverse: 5′-ACGGCATGGATCTCAAAGAC-3′), IL6
(forward: 5′-GGAAATTGGGGTAGGAAGGA-3′, reverse:
5′-CCGGAGAGGAGACTTCACAG-3′), IL1B (forward: 5′-
CTCCATGAGCTTTGTACAAG-3′, reverse: 5′-TGCTGA
TGTACCAGTTGGGG-3′), IL10 (forward: 5′-ATGCAGGA
CTTTAAGGGTTA-3′, reverse: 5′-ATTTCGGAGAGAGG
TACAAA-3′), and GAPDH (forward: 5′-TGGCAAAGTG
GAGATTGTTTG-3′, reverse: 5′-AAGATGGTGATGGGCT
TCCC-3′). For TNFα, IL-6, IL-1β, IL-10 and GAPDH an-
nealing was performed at 58 °C for 45 s. RT-PCR products
were resolved in a 1.5 % agarose gel and visualized by
staining with ethidium bromide.
Transfection of Small Interfering RNA (siRNA)
into Raw264.7 Cells
SiRNA transfection was performed as described previously
[24]. Mouse dectin-1 siRNA (sc-63277; siDec-1) was pur-
chased from Santa Cruz Biotechnology. Raw264.7 cells were
transfected with 200 nM of scrambled siRNA or dectin-1-
specific siRNAwith the GenMute siRNA and DNA transfec-
tion reagent (SignaGen Laboratories, Ijamsville, MD, USA),
according to the manufacturer’s protocol. Transfected cells
were infected with Mmass or Mabc after then harvested for
RT-PCR and ELISA.
Generation and Transduction of Small Hairpin RNA (shRNA)
Lentivirus generation and transduction of shRNA was
performed as described previously [23]. The lentiviral
construct vector pLKO.1 and three packaging plasmids
(pMDLg/pRRE, pRSV-Rev and pMD2.VSV-G) were
from Open Biosystems (Huntsville, AL, USA) and target
dectin-1 (TRCN0000066928) was from Sigma-Aldrich,
supplied as glycerol stocks. Lentivirus generation was
achieved by transfecting with Lipofectamine 2000 into
HEK 293 T cells with pLKO puro.1 or target shRNA
plasmid and the packaging plasmids. After 72 h, the
virus-containing HEK 293 T cell culture supernatants
were collected and filtered. Lentivirus determination was
performed as described previously [23]. The lentivirus
particles mixed with 8 μg/mL Polybrene (Sigma-
Aldrich) and non-specific shRNA or dectin-1 shRNA into
BMDMs, according to the manufacturer’s protocol. After
transduction, the BMDMs were harvested and the target
gene-silencing efficiency was examined by RT-PCR
analysis.
Measurement of Intracellular ROS
Intracellular ROS levels were measured as described previ-
ously [24]. Briefly, BMDMs were infected with Mmass and
washed three times in phosphate-buffered saline (PBS) to
remove extracellular bacteria. The cells were incubated
with 10 μm dihydroethidium (DHE; Calbiochem) for
30 min and fixed with 4 % paraformaldehyde at room
temperature followed by analysis with a FACSCanto II
flow cytometer (Becton Dickinson, San Jose, CA,
USA). Analysis of 30,000 events per sample was per-
formed using the FlowJo software (Tree Star; Ashland,
OR, USA).
Immunofluorescence Microscopy of NF-κB p65
Translocation
Immunofluorescence analysis was performed as described
previously [25]. Briefly, BMDMs were infected with Mmass
after they were fixed with 4 % paraformaldehyde (for 10 min)
and 0.25 % Triton X-100 (for 15 min) at RT. The cells were
stained with primary antibody (rabbit anti-mouse NF-κB p65,
1:400, for 2 h; Santa Cruz) and secondary antibody (anti-
rabbit AlexaFluor 488, 1:400, for 1 h; Invitrogen) at RT.
Nuclei were stained with 1 μg/mL DAPI (Sigma-Aldrich).
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The slides were imaged using a Zeiss LSM510META confo-
cal microscope (Zeiss, Germany).
NF-κB Luciferase Reporter Assay
The NF-κB luciferase reporter assay was performed as de-
scribed previously [25]. Briefly, cells were transduced with
adenovirus harboring NF-κB-luciferase (Genetransfer Vector
Core; Iowa City, IA, USA) for 36 h, and infected with Mmass
for 6 h. Infected cells were washed three times in PBS, and
then lysed in luciferase lysis buffer (Promega, Madison, WI,
USA). A luciferase assay system (Promega) was used accord-
ing to the manufacturer’s instructions.
Statistical Analyses
All data are presented as mean values±SD of three indepen-
dent determinations. For statistical analyses, paired t-tests with
Bonferroni adjustment or analysis of variance for multiple
comparisons were performed. Differences were considered
significant at P<0.05.
Results
Mmass Induces Proinflammatory Responses in BMDMs via
TLR2
TLRs are the best-characterized innate receptors in ini-
tiating inflammatory responses during Mtb infection
[17]. Our previous studies showed that Mabc also in-
duced innate immune response through TLR2 [26].
However, it was not known whether proinflammatory
responses are induced by Mmass infection or how these
are modulated in macrophages.
To examine this, we first measured and compared the time-
dependent expression of mRNA and proteins of proinflam-
matory cytokines in BMDMs between infection with Mmass
and Mabc. As shown in Fig. 1a and b, Mmass induced the
expression of both mRNA and protein of TNF-α and IL-6 in
BMDMs in a time-dependent manner. Mmass-induced proin-
flammatory cytokine production was comparable to that in-
duced byMabc (Fig. 1a, b).We next examined TNF-α and IL-
6 mRNA and protein expression in BMDMs from WT or
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Fig. 1 Mmass induces TNF-α and IL-6 production in a TLR2-dependent
manner. a and bBMDMs were infected with Mmass (MOI=3) or Mabc
(MOI=3) for the times indicated (0-48 h). c–f BMDMs from TLR2 WT
and TLR2KOBMDMs (cand d) or TLR4WTand TLR4KOBMDMs (e
and f) were exposed to various stimulators; Mmass, Mabc, LPS (L;
100 ng/mL), or Pam3CSK4 (P; 100 ng/mL). a, c, and eCell lysates were
collected and then subjected to semiquantitative RT-PCR for TNF-α and
IL-6. b, d, and f Infected supernatants were harvested and analyzed by
ELISA for TNF-α and IL-6. Data shown are representative of at least
three independent experiments (expressed as means±SD). *** p<0.001
(two-tailed Student’s t-test), relative to TLR2 WT (d) or TLR4 WT
conditions (f). U uninfected, MMmass, AMabc
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TLR2-KO mice, and TLR4-deficient C3H/HeJ or their con-
trol, TLR4-sufficient, C3H/HeN mice. As shown in Fig. 1c
and d, Mmass-induced TNF-α and IL-6 mRNA and protein
expression was significantly inhibited in TLR2-deficient
BMDMs. In contrast, there was no difference in
Mmass-induced TNF-α or IL-6 mRNA or protein ex-
pression in TLR4-deficient C3H/HeJ or C3H/HeN mice
(Fig. 1e, f). These data suggest that TLR2, but not
TLR4, is associated with Mmass-induced production of
TNF-α and IL-6 in BMDMs.
Mmass Induces a Proinflammatory Response Mediated
Through MyD88, but not TRIF, in BMDMs
In a previous study, Mabc-induced (C-C motif) ligand 2 and
(C-X-C motif) ligand 2 production required the MyD88-
dependent pathway [26]. However, it has not been investigat-
ed whether Mmass-induced TNF-α and IL-6 production is
mediated through the MyD88 or TRIF pathway. Thus, we
examined mRNA and protein expression of TNF-α and IL-6
in BMDMs fromWT, MyD88 KO, and TRIF KOmice, using
RT-PCR and ELISA, respectively. We found that the mRNA
and protein expression of TNF-α and IL-6 was decreased
significantly in MyD88-deficient BMDMs after Mmass infec-
tion, compared with the WT. In contrast, TRIF-deficient
BMDMs were no different than WT cells. These data show
that Mmass-induced TNF-α and IL-6 production was depen-
dent on MyD88, but not TRIF, in BMDMs (Fig. 2a, b).
Dectin-1 Does not Play a Role in Mmass-Induced
Proinflammatory Responses in BMDMs
We have previously demonstrated that Dectin-1 plays a role in
Mabc-mediated proinflammatory cytokine production in
BMDMs [24]. To determine the role of Dectin-1 in Mmass-
induced proinflammatory responses in macrophages,
RAW264.7macrophage cells were transfected with scrambled
siRNA (siNS) or siRNA targeting Dectin-1 (siDec-1) prior to
Mmass infection. In Dectin-1-knocked down cells, mRNA
and protein synthesis of TNF-α and IL-6 was not decreased,
when compared with those transfected with scrambled siRNA
(siNS; Fig. 3a, b). Additionally, downregulation of Dectin-1 in
BMDMs with shRNA specific to Dectin-1 (shDec-1) partially
attenuated Mabc-, but not Mmass-, induced proinflammatory
cytokine mRNA and protein expression (Fig. 3c, d). Consis-
tent with our previous findings, Mabc-induced production of
TNF-α and IL-6 was significantly inhibited in Dectin-1-
knocked down RAW264.7 cells (Fig. 3a, b) and BMDMs
(Fig. 3c, d). Together, these data suggest that Dectin-1 is not
involved in Mmass-induced proinflammatory cytokine gener-
ation in macrophages.
Mmass-Induced Proinflammatory Cytokine Generation is
Mediated Through a JNK-Dependent Pathway
In mycobacterial infection, MAPK activation is important for
the regulation of innate immune responses and the production
of various effector molecules in macrophages [19]. We
showed previously that MAPK is activated and plays a role
in inflammatory responses in macrophages upon Mabc infec-
tion [24]. When we infected BMDMs with Mmass, we found
that Mmass robustly activated the MAPK signaling pathway
(JNK, ERK1/2, and p38) in macrophages in a time-dependent
manner (Fig. 4a). Consistent with previous reports [24],
BMDMs infected with Mmass showed peak levels of MAPK
activation at 15 and 30 min postinfection (Fig. 4a).
To investigate whether the MAPK pathway plays a role in
Mmass-induced proinflammatory responses in macrophages,
we pretreated macrophages with pharmacological inhibitors
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Fig. 2 MyD88, but not TRIF, is required for Mmass-induced TNF-α and
IL-6 production. a and bBMDMs from WT, MyD88 KO, and TRIF KO
BMDMs were exposed to various stimulators; Mmass (MOI=3), Mabc
(MOI=3), LPS (L; 100 ng/mL), or Pam3CSK4 (P; 100 ng/mL). aThe cell
lysates were collected and then subjected to semiquantitative RT-PCR for
TNF-α and IL-6. b The infected supernatants were harvested and then
analyzed by ELISA for TNF-α and IL-6. Data shown are representative
of at least three independent experiments (expressed as means±SD).
** p<0.01, *** p<0.001 (two-tailed Student’s t-test), compared with
WT condition. U uninfected, MMmass, AMabc
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of the MAPK pathways and measured TNF-α and IL-6 se-
cretion uponmycobacterial infection. As shown in Fig. 4b and
c, Mmass-induced TNF-αmRNA and protein production was
dose-dependently blocked in the presence of a JNK inhibitor
(SP600125), but not inhibitors of the ERK1/2 (U0126) or p38
(SB203580) pathways. These data indicate that the JNK path-
way is required for Mmass-induced TNF-α and IL-6 produc-
tion in BMDMs.
Mmass-Induced NF-κB Signaling is Required
for Proinflammatory Cytokine Generation in BMDMs
In mycobacterial infection, the NF-κB signaling pathway
plays a key role in the induction of inflammatory cytokine
generation and antimicrobial protein synthesis in TLR-
triggered innate immune responses [18, 27]. To determine
whether Mmass activated the NF-κB signaling pathway, we
performed a NF-κB luciferase assay in BMDMs transduced
with adenovirus encoding a luciferase reporter plasmid con-
taining response elements for NF-κB (Ad-NF-κB-Luc). As
shown in Fig. 5a, Mmass infection strongly increased NF-κB
reporter gene activities in BMDMs transduced with Ad-
NF-κB-Luc, in a multiplicity of infection (MOI)-dependent
manner. There was no significant increase in NF-κB promoter
activities in BMDMs transducedwith control adenovirus (data
not shown). We also determined that Mmass infection stimu-
lated the translocation of NF-κB p65 from the cytoplasm to
the nucleus, as assessed using confocal microscopy after
30 min of infection (Fig. 5b).
We next examined whether NF-κB signaling was involved
in the induction of mRNA expression of TNF-α and IL-6 in
response to Mmass. As shown in Fig. 5c and d, Mmass-
induced TNF-α and IL-6 production was dose-dependently
abrogated in BMDMs by pretreatment with Bay 11-7082
(BAY) or caffeic acid phenethyl ester (CAPE), specific inhib-
itors of the NF-κB signaling pathway. From these results,
Mmass-induced NF-κB signaling activation is required for
proinflammatory cytokine generation in BMDMs.
Mmass-Induced Proinflammatory Cytokine Generation
is Dependent on NOX2-Dependent ROS Generation
in BMDMs
Previous studies suggested that ROS generation played mul-
tiple roles, in mycobacterial killing, regulation of cell death,
cytokine production, and antimicrobial protein activation, in
TLR-triggered innate immune responses [22, 28]. We first
examined whether Mmass induced BMDMs using the oxida-
tive fluorescent dye dihydroethidium (DHE) to determine
intracellular superoxide generation. As shown in Fig. 6a,
Mmass-induced superoxide production was detected rapidly.
We next examined whether infection with Mmass-dependent
ROS generation was required for cytokine expression and
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Fig. 3 Mmass-induced TNF-α and IL-6 production is not mediated
through Dectin-1. a and b Raw 264.7 cells were transfected with non-
specific siRNA (siNS) or specific siRNAs against mouse dectin-1 (siDec-
1) following infection with Mmass (MOI=3) or Mabc (MOI=3). c and d
BMDMs were transduced with non-specific shRNA lentiviral particles
(shNS) or lentiviral shRNA specific to dectin-1 (shDec-1), following
infection with Mmass or Mabc. a and c The cell lysates were collected
and then subjected to semiquantitative RT-PCR for TNF-α, IL-6, and
dectin-1. b and d The infected supernatants were harvested and then
subjected to ELISA analysis for TNF-α and IL-6. Data shown are
representative of at least three independent experiments (expressed as
means±SD). ** p<0.01, *** p<0.001 (two-tailed Student’s t-test), rela-
tive to si-NS (b) or sh-NS (d). U uninfected, MMmass, AMabc
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general ROS scavenger NAC, the NADPH oxidase inhibitor
DPI, and the superoxide scavenger Tiron, dose-dependently
decreased Mmass-induced mRNA expression and protein
production of TNF-α and IL-6 in BMDMs (Fig. 6b, c). Pre-
viously, it has been shown that mycobacterial infection
BMDMs involves significant levels of NOX2 expression
[22]. Thus, we further investigated the role of NOX2 in
infection and Mmass-mediated cytokine production. Mmass-
induced mRNA expression and production of TNF-α and IL-
6 in BMDMs from NOX2 KO mice were nearly abolished,
compared with WT controls (Fig. 6d, e). We next examined
the interaction between the JNK and ROS signaling pathways.
BMDMs were pre-treated with antioxidants followed by
Mmass stimulation. We found that pre-treatment with ROS
blockers significantly decreased JNK phosphorylation in a
dose-dependent manner (Fig. 6f). These findings suggest that
NOX2-dependent generation of ROS is involved in Mmass-
mediated inflammatory cytokine induction and JNK signaling
in infection in murine macrophages.
R Morphotypes of Mmass Elicit Higher Production
of Proinflammatory Cytokines and JNK Activation Than S
Morphotypes
Previous studies showed thatMabc R variants were associated
with TLR2-dependent hyper-proinflammatory responses via
increased synthesis/exposure at the cell surface of lipoproteins
[29]. However, the association between bacterial colony
morphotypes and innate immune responses in Mmass infec-
tion has not been characterized. To examine whether there was
any relationship between morphotypes of Mmass and inflam-
matory responses in macrophages, we infected murine
BMDMs with four strains: two smooth (S1 and S2) and two
rough types (R1 and R2). As shown in Fig. 7a and b, the
mRNA and protein expression of TNF-α and IL-6 were
increased significantly in BMDM after Mmass R morphotype
infection, compared with those with S morphotype infection.
When phospho-JNK levels were compared among BMDMs
infected with various clinical strains, the R morphotype in-
duced higher activation of JNK than S morphotype in
BMDMs (Fig. 7c). Moreover, the NF-κB luciferase assay
showed that the R morphotypes of Mmass induce higher
levels of luciferase activity than S morphotypes (Fig. 7d).
These data show that the R morphotypes of Mmass induced
greater proinflammatory cytokine release along with in-
creased activation of JNK and NF-κB signaling pathways
compared with the S morphotypes.
Discussion
Mabc complex, the second most common cause of atypical
mycobacterial infection following M. avium-intracellulare
complex, is the most virulent RGM. These infections are
frequently associated with infectious diseases affecting the
lungs, skin, or soft tissues [30]. In recent years, the members
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Fig. 4 Mmass-induced inflammatory cytokine production is mediated
via c-JunN-terminal family kinases in BMDMs. aBMDMswere infected
with Mmass (MOI=3) for the indicated times (0-480 min). The cell
lysates were collected and then subjected to Western blotting for
phospho-JNK, phospho-ERK1/2, and phospho-p38. β-actin was used
as a loading control. b and c BMDMs in the presence or absence of a
JNK inhibitor (SP600125; 5, 20, or 30 μM), MEK-1 inhibitor (U0126; 5,
10, or 20 μM), or p38 inhibitor (SB203580; 1, 5, or 10 μM) for 45 min,
before infection with Mmass. b The cell lysates were collected and then
subjected to semiquantitative RT-PCR for TNF-α and IL-6. cThe infected
supernatants were harvested and then subjected to ELISA for TNF-α and
IL-6. Data shown are representative of at least three independent exper-
iments (expressed as means±SD). *** p<0.001 (two-tailed Student’s t-
test), relative to the solvent control. U uninfected, D solvent control
(0.05 % DMSO), SP SP600125, SB SB203580
218 J Clin Immunol (2014) 34:212–223
ofMabc complex, Mmass andM. bolletiiwere identified from
other RGM species through genetic investigations. The devel-
opment of 16S rRNA gene sequence analysis and the se-
quencing of rpoB, sodA, and hsp65 genes of NTM resulted
in species-specific identification of Mmass [31]. Moreover,
recent studies have shown that mycobacterial genotyping
between Mabc and Mmass shows a significant association
of specific genotypes with clinical phenotypes and disease
progression [32]. Inflammatory responses play important
roles in host defense and in dictating immunopathogenesis
during mycobacterial infection [33, 34]. Bacterial growth and
infection-induced mortality were significantly increased in a
TNF-deficient mouse model of Mabc infection; however,
these findings were not observed with the subspecies
M. chelonae [15]. Although there has been significant
progress in identifying Mmass from other Mabc com-
plex species, little is known about the host inflammato-
ry responses to Mmass.
Compared with tuberculosis, much less is known about the
roles of TLRs in atypical mycobacterial infection. Our study
showed that Mmass robustly activated macrophage inflam-
matory responses through TLR2 and MyD88, but not Dectin-
1. Earlier studies showed that lipomannans purified from
M. chelonae and a clinical strain of M. kansasii induced
mRNA expression and secretion of TNF-α and IL-8 from
human THP-1 cells by a TLR2-dependent mechanism [35].
Mabc-mediated TNF-α production is abrogated in TLR2- or
MyD88-deficient BMDMs, reinforcing a critical role for
TLR2-MyD88 in Mabc-induced macrophage activation [36].
Our previous studies also showed that TLR2 and Dectin-1 are
a b
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Neuclei NF- B p65 Merge
Fig. 5 Mmass robustly increased the production of inflammatory cyto-
kines via NF-κB activation in BMDMs. aBMDMs were transduced with
NF-κB adenovirus luciferase construct and infected with Mmass (MOI=
1 or 3) and LPS (L; 100 ng/mL) for 6 h. The cell lysates were harvested
and assayed for luciferase reporter activity. bBMDMs were infected with
Mmass (M; MOI=3) for 30 min. Then, the cells were immunolabeled
with anti-NF-κB p65 antibody, anti-rabbit-AlexaFluor 488 (green), and
DAPI to visualize the nuclei (blue). Representative immunofluorescence
images (upper) and the average mean fluorescence intensity of cells
exhibiting NF-κB nuclear translocation (lower) are shown. Scale bars=
20 μm. cand dBMDMswere cultured in the presence or absence of BAY
11-7082 (BAY; 0.3, 1, or 3 μM, for 45 min) or CAPE (1, 5, or 10 μM, for
2 h) before infection with Mmass. cCell lysates were collected and then
subjected to semiquantitative RT-PCR for TNF-αand IL-6. dThe infected
supernatants were harvested and then subjected to ELISA for TNF-α and
IL-6. Data shown are representative of at least three independent exper-
iments (expressed as means±SD). * p<0.05, *** p<0.001 (two-tailed
Student’s t-test), relative to the solvent control. U uninfected, D solvent
control (0.05 % DMSO)
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involved in the production of proinflammatory cytokines and
chemokines to M. ulcerans or Mabc in human keratinocytes
and murine macrophages, respectively [24, 37]. Dectin-1 is a
type II transmembrane non-opsonic receptor and plays a key
role in the binding and response to fungal-derived β-1,3 and
β-1,6 glucan particles [38, 39]. It is expressed on most
immune cells involved in innate immunity and plays an es-
sential role in phagocytosis and antifungal activities in mac-
rophages [38, 39]. In mycobacterial infections, signaling
through Dectin-1 is required for the production of several
cytokines, including IL-6, RANTES (regulated on activation,
normal T expressed, and secreted), and granulocyte colony-
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Fig. 6 Intracellular ROS generation is involved in Mmass-induced cy-
tokine production. a FACS analysis of BMDMs were infected with
Mmass (MOI=3) for 30 min, and stained with DHE for 30 min. Repre-
sentative images (upper) and quantitative analysis of mean fluorescence
intensities (lower) are shown. b, c, and f BMDMs were cultured in the
presence or absence of an antioxidant (NAC; 10, 20, or 30 mM), a
NADPH oxidase inhibitor (DPI; 1, 5, or 10 μM), or a superoxide
scavenger Tiron (10, 20, or 30 mM) for 45 min, before infection with
Mmass. d and eBMDMs from NOX2WTand NOX2 KO BMDMs were
infected with Mmass (M) for the indicated times (0-18 h). b and d Cell
lysates were collected and then subjected to semiquantitative RT-PCR for
TNF-α and IL-6. c and e The infected supernatants were harvested and
then subjected to ELISA analysis for TNF-α and IL-6. fCell lysates were
collected and then analyzed by Western blotting for phospho-JNK; β-
actin was used as a loading control. Data shown are representative of at
least three independent experiments (expressed as means±SD).
** p<0.01, *** p<0.001 (two-tailed Student’s t-test), compared with
the solvent control (c) or NOX2 WT (e). U uninfected, D solvent control
(0.05 % DMSO)
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stimulating factor by macrophages [40]. Importantly, Mabc
infection leads to activation of the NLRP3 inflammasome and
caspase-1 cleavage in human monocyte-derived macrophages
via Dectin-1 [23].
Mmass-induced JNK and NF-κB signaling pathways play
an essential role in the production of TNF-α and IL-6 in
BMDMs. After engagement of innate immune receptors by
mycobacterial strains, the intracellular signaling pathways,
including the MAPK family and NF-κB signaling, lead to
activation of the synthesis of innate effectors and inflamma-
tory mediators in mononuclear phagocytes [16, 18, 19]. Re-
cent studies have shown that monocytes from patients with
Mabc lung infection have decreased MAPK activity and
production of proinflammatory cytokines, including TNF-α
and IL-6 [41]. However, Mabc induces higher production of
proinflammatory cytokines and chemokines through the
TLR2 and MAPK pathways than M. avium [36]. In human
cells, Mabc-induced TNF-α production depends on the acti-
vation of the ERK1/2 and p38 MAPK pathways [36]. Further,
M. avium infection prior to BCG resulted in the production of
IL-10 in dendritic cells through the TLR2-p38 MAPK signal-
ing pathway [42]. Our data are unique in demonstrating the
critical role of JNK signaling in proinflammatory responses to
Mmass in macrophage infection. Mmass-induced ROS gen-
eration was required for proinflammatory cytokine responses
in macrophages. In a previous study we found that the ROS
production played an essential role in autophagy and proin-
flammatory cytokine production in Mtb-eis-infected BMDMs
[28]. We have recently shown that Mabc infection of macro-
phages leads to the induction of CCL2 through ROS-mediated
NF-κB signaling activation [26]. Cellular ROS are required
for the cutaneous innate immune responses, through inhibition
of intracellular M. ulcerans growth in keratinocytes [37].
These findings suggest a novel role for ROS signaling in the
activation of macrophage inflammatory responses, in particu-
lar, by activating JNK-dependent mechanisms in infected
macrophages.
To our knowledge, this is the first report that S
morphotypes of Mmass elicit less profound effects on innate
immune signaling through JNK activation in macrophages. A
variety of clinical strains of atypical mycobacteria show di-
versity in colony morphology: R and S colony phenotypes
among NTM strains [43]. A recent study involving genome-
and transcriptome-wide analyses identified newly defined
genetic lesions responsible for glycopeptidolipids, which con-
trol switching between the R and S morphologies in Mabc
[44]. R variants of Mabc markedly activate the innate immune
response through TLR2, while S variants do not, partly due to
the deficiency of cell wall glycopeptidolipids, which masks
underlying cell wall lipid components involved in induction of
inflammatory responses [45]. Moreover, the R variant of
Mabc infection led to hyperlethality in mice [46] and was
found to be associated with severe clinical phenotypes char-
acterized by hyper-inflammatory responses [29]. Interestingly,
Mabc isolated from the upper lobe fibrocavitary form of
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Fig. 7 Inflammatory expression is upregulated in rough-type clinical
strain-infected murine macrophages. a–dBMDMs were infected with type
strain A (MOI=3), smooth-type clinical strains (S1 and S2; MOI=3) and
rough-type clinical strains (R1 and R2; MOI=3). a The cell lysates were
collected and then subjected to semiquantitative RT-PCR for TNF-αand IL-
6. bThe infected supernatants were harvested and then subjected to ELISA
analysis for TNF-α and IL-6. cBMDMs were infected with Mmass strains
for the indicated times (5 and 15 min). Cell lysates were collected and then
subjected to Western blotting for phospho-JNK. β-actin was used as a
loading control. dBMDMs were transduced with NF-κB adenovirus lucif-
erase construct and infected with each type of Mmass or LPS (L; 100 ng/
mL). Cell lysates were harvested and assayed for luciferase reporter activity.
Data shown are representative of at least three independent experiments
(expressed as means±SD). ** p<0.01, *** p<0.001 (two-tailed Student’s t-
test), relative toMmass type strain infection.Uuninfected, A type strain CIP
108297, S1 smooth-type clinical strain KMRC00136-13008, S2 smooth-
type clinical strain KMRC00136-13011, R1 rough-type clinical strain
KMRC00136-13009, R2 rough-type clinical strain KMRC00136-13012
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pulmonary Mabc infection was associated with stronger in-
flammatory responses and increased bacterial loads in the
lungs of infected mice compared to the nodular bronchiectatic
form of disease [47]. However, previous studies reported no
significant difference in human cell secretion of TNF-α be-
tween infection with R and S isolates of Mabc or M. avium
[36]. Differences in the inflammatory responses induced by
each Mabc subspecies, along with the clinical phenotypes
associated with each subspecies, are beginning to be recog-
nized. Additional studies clarifying the relationship between
Mmass-induced inflammatory responses and clinical manifes-
tations of infection are urgently needed. Taken together, our
data suggest that Mmass activates macrophage innate immune
responses through TLR2-dependent JNK, NF-κB, and ROS
signaling pathways. These in vitro effects may be associated
with the inflammatory responses and clinical features, and
may support the development of new therapeutics for
Mmass-mediated atypical mycobacterial infection.
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